Client: Reputed Brokerage and Investment Group
Client Goal: Client wanted to invest in a pharmaceutical company that has focus on manufacturing Intravenous Fluids.
Situation: Being a reputed investment group, client wanted to understand market risk before investing into pharmaceutical company. Interlink being a Pharma consultancy firm having three decades of experience; client wanted Interlink to conduct a market risk assessment study for mid-sized pharmaceutical company manufacturing Intravenous fluids.
Interlink’s role: Interlink experts and consultants conducted primary and secondary research, analyzed data provided by pharmaceutical company, conducted market overview study, validated the project initiatives, financial viability and projections. Interlink in co-operation with client company covered all those issues which are significant for market risk analysis in a period of 2 months.
Impact: Market risk assessment report was approved by Client Company and they were ready to invest in pharmaceutical company.